Alpha Paradigm Partners’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-131,064
Closed -$2.18M 613
2022
Q3
$2.18M Buy
131,064
+81,733
+166% +$1.84M 0.94% 10
2022
Q2
$982K Buy
49,331
+10,293
+26% +$208K 0.41% 70
2022
Q1
$1.08M Sell
39,038
-1,251
-3% -$35.8K 0.42% 57
2021
Q4
$1.66M Buy
+40,289
New +$1.78M 0.67% 22
2021
Q3
Sell
-72,342
Closed -$2.89M 679
2021
Q2
$2.89M Buy
+72,342
New +$3.09M 1.09% 4

Other funds holding VCYT

Alpha Paradigm Partners's VCYT Position: Q4 2022 in Review

Alpha Paradigm Partners sold out of Veracyte (VCYT) in Q4 2022, closing a stake of 131,064 shares — an estimated $2.18M sold.

Alpha Paradigm Partners first reported a position in VCYT in Q2 2021 and held it in 5 quarters. The position peaked at $2.89M in Q2 2021. 223 funds tracked by Wall St. Rank hold VCYT as of Q4 2022.

  • Alpha Paradigm Partners reported no remaining Veracyte position as of Q4 2022 after selling out during the quarter.
  • Alpha Paradigm Partners sold 131,064 Veracyte shares in Q4 2022, an estimated $2.18M.
  • Alpha Paradigm Partners first reported a position in Veracyte in Q2 2021 and held it in 5 quarters.
  • Alpha Paradigm Partners's Veracyte position peaked at $2.89M in Q2 2021.
  • 223 funds tracked by Wall St. Rank held Veracyte as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.